2.3. IL-13Rα2 Is Involved in Resistance to the Cytotoxic Effect of Doxorubicin and Silencing of IL-13Rα2 Sensitized Osteosarcoma Cells to Doxorubicin. Here, IL13RA2 is linked to osteosarcoma.